Quest Diagnostics Trading Volume Surges 97% to $312 Million Ranking 451st in Market

On April 3, 2025, Quest Diagnostics (DGX) saw a significant surge in trading volume, with a turnover of $312 million, marking a 97.04% increase from the previous day. This substantial rise in trading activity placed DGX at the 451st position in the day's stock market rankings. The stock price of Quest Diagnostics also experienced a notable increase, rising by 1.59%.

Redburn Atlantic has initiated coverage on Quest Diagnostics, assigning a Buy rating and setting a price target of $195. This move by Redburn Atlantic, led by analyst Jamie Clark, reflects a positive outlook on the company's prospects. The Buy rating and the $195 price target indicate confidence in Quest Diagnostics' future performance and potential for growth.